Skip to content

Comparison of the Effect of Ketorolac injection in the muscle and that at the site of wound of surgery for Pain Relief after Laparoscopic Surgery of Gall Bladder.

Comparison of the Effect of Administration of Ketorolac IM and Local Infiltration of Ketorolac for Pain Relief after Laparoscopic Cholecystectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028916
Enrollment
60
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: IM injection and local infilteration of Ketorolac: After laproscopic cholecystectomy either injection Ketorolac will be administered im or infilterated locally at the sites of port inse

Sponsors

Dr Shagufta Naaz
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA I and II 2. Patients between the ages of 35-65 years 3. Duration of surgery less than 2 hrs 4.Male and female 5. BMI 18-30kg/m2

Exclusion criteria

Exclusion criteria: 1. History of severe liver, renal or cardiovascular disease or chronic pain disease 2. Pre-existing neurological or psychiatric illness 3. Any bleeding abnormality 4. Diagnosis of asthma or allergy 5. Sensitivity to NSAIDs, any ulcer 6. History of alcohol or drug abuse 7. History of chronic use of analgesics, sedatives, opioids, or steroids 8. Pregnancy

Design outcomes

Primary

MeasureTime frame
The duration of AnalgesiaTimepoint: After surgery

Secondary

MeasureTime frame
the patient outcome and associated adverse effect.Timepoint: After injection Ketorolac

Countries

India

Contacts

Public ContactShagufta Naaz

AIIMS Patna

drshaguftanaaz@gmail.com07765937919

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026